Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb;27(2):636-638.
doi: 10.3201/eid2702.201960. Epub 2020 Dec 21.

Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020

Maryam Shakiba, Maryam Nazemipour, Arsalan Salari, Fardin Mehrabian, Seyed Saeed H Nazari, Seyed Mahmoud Rezvani, Zahra Ghasempour, Abtin Heidarzadeh, Mohammad Ali Mansournia

Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020

Maryam Shakiba et al. Emerg Infect Dis. 2021 Feb.

Abstract

We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%-28.5%).

Keywords: COVID-19; Guilan; Iran; SARS-CoV-2; asymptomatic infections; coronavirus disease; respiratory infections; seroprevalence; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

PubMed Disclaimer

References

    1. World Health Organization. Coronavirus disease (COVID-19) situation reports 2020. [cited 2020 Aug 10]. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situatio...
    1. Russell TW, Hellewell J, Jarvis CI, van Zandvoort K, Abbott S, Ratnayake R, et al. ; Cmmid Covid-Working Group. Estimating the infection and case fatality ratio for coronavirus disease (COVID-19) using age-adjusted data from the outbreak on the Diamond Princess cruise ship, February 2020. Euro Surveill. 2020;25:2000256. 10.2807/1560-7917.ES.2020.25.12.2000256 - DOI - PMC - PubMed
    1. Clapham H, Hay J, Routledge I, Takahashi S, Choisy M, Cummings D, et al. Seroepidemiologic study designs for determining SARS-COV-2 transmission and immunity. Emerg Infect Dis. 2020;26:1978–86. 10.3201/eid2609.201840 - DOI - PMC - PubMed
    1. Mansournia MA, Altman DG. Inverse probability weighting. BMJ. 2016;352:i189. 10.1136/bmj.i189 - DOI - PubMed
    1. Cassaniti I, Novazzi F, Giardina F, Salinaro F, Sachs M, Perlini S, et al. ; Members of the San Matteo Pavia COVID-19 Task Force. Performance of VivaDiag COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department. J Med Virol. 2020;92:1724–7. 10.1002/jmv.25800 - DOI - PMC - PubMed

Publication types

Substances